CLSI eNews - 11 February 2005
(Plain Text Version)
Return to Graphical Version | Search
back issues | Print
all articles
In this issue:
Note on printing single articles: Each selected individual article will
appear at the bottom of this screen...please scroll down to view/print
the selected article.
News
Executive Vice President's Message
Nationally Recognized Experts to Speak at Equivalent Quality Control Workshop: QC for the Future
Celebrate Our New Name: Clinical and Laboratory Standards Institute
IQLM Landmark Summit to Honor Leaders in Quality
Press Releases
Standards Status
Notice of Vote and Comment Deadline for Consensus Documents
Recently Approved Documents
Recently Distributed ISO Standards
Focus on Global Terminology
Notice of M100-S15 (M7) Table 3A Erratum
Events and Exhibits
Meeting Calendar
Upcoming Events and Exhibits
Membership
Join Us
New and Sustaining Members
Update Your Subscriptions
Notice of M100-S15 (M7) Table 3A Erratum
We have identified the following error in document M100-S15 (M7), MIC Testing Supplemental Tables.
In Table 3A, Acceptable Limits for Quality Control Strains Used to Monitor Accuracy of Minimal Inhibitory Concentrations (MICs) (mg/mL) of Fastidious Organisms (page 142), the MIC ranges for Haemophilus influenzae ATCC® 49247 were misaligned, beginning with erythromycin. Correct ranges are as follows:
|
Antimicrobial Agent |
Haemophilus influenzae ATCC® 49247 a |
|
Erythromycin |
– |
|
Fleroxacin |
0.03–0.12 |
|
Garenoxacin |
0.002-0.008 |
|
Gatifloxacin |
0.004–0.03 |
|
Gemifloxacin |
0.002–0.008 |
|
Gentamicin |
– |
|
Grepafloxacin |
0.002–0.015 |
|
Imipenem |
– |
|
Levofloxacin |
0.008–0.03 |
|
Linezolid |
– |
|
Lomefloxacin |
0.03–0.12 |
|
Loracarbef |
– |
|
Meropenem |
– |
|
Metronidazole |
– |
|
Moxifloxacin |
0.008–0.03 |
|
Nitrofurantoin |
– |
If you have not received a corrective label (for purchasers of paper documents) or a corrected PDF file (for purchasers of electronic documents) by 15 February 2005, please contact Linda Charles (extension 115) or Sheryl Wildgust (extension 130) at the Executive Offices +610.688.0100.
Thank you for your assistance. We regret any inconvenience.
For more information or to contact us directly, please visit www.clsi.org
l ©2005 Clinical and Laboratory Standards
Institute
|